Close Menu

Grants

Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Title Type $ Amount Activity Investigatorsort descending Unit Sponsor Date
The Automated Diseases Activity Monitoring System (ADAMS) Contract $824,548.00 Research - Industry (62.5% MTDC) Frederic Zenhausern COM Phx NanoBioscience & Med Costa Devices Limited 10/2020
Product Development of the Vertical Integrated Flow Assay System Technology ("VERIFAST") for Multiplex Pathogens Detection Contract $4,364,034.00 Research Frederic Zenhausern COM Phx NanoBioscience & Med Advanced Technology International 04/2020
Characterizing the Molecular Mechanisms of Centriole Duplication, Growth and Maturation Grant $2,610,757.00 Research Gregory Rogers Cellular & Molecular Medicine National Institute of General Medical Sciences 07/2020
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Transarterial Chemoembolization (TACE) in Combination with Either Durvalumab Monotherapy or Durvalumab Plus Bevacizumab Contract $208,612.70 Clinical Trial Gregory Woodhead Cancer Center Division Astrazeneca 06/2020
Low Cost Detector for Cardiac SPECT Imaging Grant $110,044.00 Research H Barber Medical Imaging Radiation Monitoring Devices, Incorporated 03/2020
A Phase I/II Pilot Trial, Single Arm, Open Label, of Protein-bound Paclitaxel, Cisplatin, And Gemcitabine (GCN) Combined with Tumor Treatment Fields (TTF) in Patient with Metastatic Pancreatic... Contract $161,422.69 Clinical Trial Hani Babiker Cancer Center Division NovoCure 09/2020
A Randomized, Phase 3 Study of Eryaspase in Combination with Chemotherapy versus Chemotherapy Alone as Second-Line Treatment in Patients with Pancreatic Adenocarcinoma (TRYbeCA-1 - TRial of ErYaspase Contract $664,687.53 Clinical Trial Hani Babiker Cancer Center Division PPD Investigator Services, LLC. 05/2020
A Phase 1 Study Evaluating the Safety, Pharmacokinetics, and Anti-Tumor Activity of ABBV-321 in Subjects with Advanced Solid Tumors Associated with Overexpression of the Epidermal Growth Factor Recept Contract $854,975.00 Clinical Trial Hani Babiker Cancer Center Division AbbVie Incorporated 10/2020
Phase 1 Study of VE800 and Nivolumab in Patients with Selected Types of Advanced or Metastatic Cancer Contract $323,394.75 Clinical Trial Hani Babiker Cancer Center Division Vedanta Biosciences, Inc. 05/2020
A Phase 1, Open-label Study of ASP9801, an Oncolytic Virus, Administered by Intratumoral Injection in Patients with Advanced/Metastatic Solid Tumors Contract $458,027.74 Clinical Trial Hani Babiker Cancer Center Division Parexel International Corporation 01/2020
Phase 3b Study for Evaluation of Efficacy and Nutritional Benefits of Pancrelipase in Patients with Exocrine Pancreatic Insufficiency due to Periampullary and Pancreatic Cancer Contract $122,409.40 Clinical Trial Hani Babiker Cancer Center Division AbbVie Incorporated 01/2020
A Phase 1 Study of ERK1/2 Inhibitor JSI-1187 Administered as Monotherapy and in Combination with Dabrafenib for the Treatment of Advanced Solid Tumors with MAPK Pathway Mutations Contract $643,931.75 Clinical Trial Hani Babiker Cancer Center Division Strategia Therapeutics 06/2020
Epitope Open-Label Extension Study to Evaluate the Long-Term Clinical Benefit and Safety of DBV712 in Peanut-Allergic Children (EPOPEX) Contract $173,290.72 Clinical Trial Heather Cassell Asthma/Airway Disease Rsch Ctr Pharmaceutical Research Associates 02/2020
Novel Gene Based Therapy for Nemaline Myopathy Grant $88,792.00 Research Hendrikus Granzier Cellular & Molecular Medicine Hospital for Sick Children (Canada) 05/2020
Web-based Physical Activity Intervention for Children with ALL Grant $175,000.00 Clinical Trial Holly Pariury Cancer Center Division Children's Hospital of Philadelphia 09/2020
COG NCTN Network Group Operations Center Contract $750,000.00 Clinical Trial Holly Pariury Cancer Center Division Children's Hospital of Philadelphia 10/2020
Children's Oncology Group NCORP Research Base Contract $750,000.00 Clinical Trial Holly Pariury Cancer Center Division Children's Hospital of Philadelphia 10/2020
Microbiota Control Lung Th17 Cell Response and Plasticity Leading to Autoimmune Lung Disease Grant $1,776,972.00 Research Hsin-Jung Wu Immunobiology National Heart, Lung, and Blood Institute 07/2020
MIS General Surgery Fellowship Grant (AY 2021-2022) Fellowship $20,000.00 Research Training Iman Ghaderi Surgery Foundation for Surgical Fellowships 06/2020
MIS General Surgery Fellowship Grant (2020-2021) Fellowship $20,000.00 Research Training Iman Ghaderi Surgery Foundation for Surgical Fellowships 01/2020
Establishing Glyoxalase 2 as a Viable Target for the Treatment of Disease Grant $1,886,815.00 Research James Galligan Pharmacology and Toxicology National Institute of General Medical Sciences 07/2020
University of Arizona COVID-19 Serology Testing Contract $3,500,000.00 Research Janko Nikolich-Zugich UAHS Research Arizona Department of Health Services 06/2020
Impact of Senescence on T-cell Function and Immunotherapeutic Response Grant $19,898.00 Research Janko Nikolich-Zugich Immunobiology Ohio State University 06/2020
A Randomized, Placebo-Controlled, Double-Blind Study of Adjuvant Cemiplimab Versus Placebo after Surgery and Radiation Therapy in Patients with High Risk Cutaneous Squamous Cell Carcinoma Contract $258,643.47 Clinical Trial Jared Robbins Cancer Center Division Regeneron Pharmaceuticals, Inc 02/2020
A Randomized, Double-blind, Placebo-controlled, Clinical Trial of LY3127804 in Patients who are Hospitalized with Pneumonia and Presumed or Confirmed COVID-19 Contract $1,181,507.00 Clinical Trial Jarrod Mosier Dept of Emergency Medicine Target Health, LLC 10/2020

Pages